Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000022096 | SCV000917412 | pathogenic | Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | 2017-10-30 | criteria provided, single submitter | clinical testing | Variant summary: The GALT c.377+53_1059+87del variant involves the deletion of exons 5-10 and is predicted to result in frameshift. This may cause a truncated or absent GALT protein due to nonsense mediated decay, which is commonly known mechanisms for disease. The frequency of this variant in the general population could not be determined as the technology used for large population databases (ExAC, ESP, 1000G) cannot detect duplications this large. This variant has been reported in one galactosemia family and is absent in 100 control chromosomes (Gort_2006). In addition, one other clinical diagnostic laboratory classified this variant as pathogenic. Taken together, this variant is classified as pathogenic. |